openPR Logo
Press release

Anti-Obesity Drugs Market Size to rise at 23% CAGR through 2028 | Novo Nordisk A/S, GlaxoSmithKline plc, VIVUS LLC, Currax Pharmaceuticals LLC, F. Hoffamann-La Roche Ltd., Pfizer Inc.

01-24-2023 06:31 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Market Study Report

/ PR Agency: Market Study Report
Anti-Obesity Drugs Market Size to rise at 23% CAGR through 2028 |

Market Study Report has added a new report on Anti-Obesity Drugs Market with respect to the pivotal drivers influencing the revenue graph of this business sphere. The current trends of Anti-Obesity Drugs market in conjunction with the geographical landscape, demand spectrum, remuneration scale, and growth graph of this vertical have also been included in this report.

For More Details on This Report: https://www.marketstudyreport.com/reports/global-anti-obesity-drugs-market-analysis-and-forecast-2022-2028

Global Anti-Obesity Drugs Market Analysis and Forecast, 2022-2028

The global anti-obesity drugs market is expected to grow at a CAGR of around 23% over the forecast period of 2022-2028.

Global Anti-Obesity Drugs Market Report 2022 comes with the extensive industry analysis with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2022-2028.This research study of Anti-Obesity Drugs involve the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies, and the technical progress in related industry.

Leading Companies and Market Players

Novo Nordisk A/S
GlaxoSmithKline plc
VIVUS LLC
Currax Pharmaceuticals LLC
F. Hoffamann-La Roche Ltd.
Pfizer Inc.
Sandoz International GmbH
Boehringer Ingelheim International GmbH
Arena Pharmaceuticals Inc.
Takeda Pharmaceuticals Company Ltd.
Merck & Co. Inc.
Eisai Co. Ltd.
Novo Nordisk

Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt and will significantly affect the Anti-Obesity Drugs market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.

Request Sample copy of this Report @ https://www.marketstudyreport.com/request-a-sample/5659616/

Global Anti-Obesity Drugs Market Segmentation

Global Anti-Obesity Drugs Market Research report comprises of Porter's five forces analysis to do the detail study about its each segmentation like Product segmentation, End user/application segment analysis and Major key players analysis mentioned as below.

By Type, Anti-Obesity Drugs market has been segmented into:

Prescription Drugs
OTC Drugs

By Application, Anti-Obesity Drugs market has been segmented into:

Refractories
Foundry
Kiln Furniture

Regional Analysis:

North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)

Scope of the Report

- To analyze and forecast the market size of the global Anti-Obesity Drugs market.

- To classify and forecast the global Anti-Obesity Drugs market based on product, application, end user, region.

- To identify drivers and challenges for the global Anti-Obesity Drugs market.

- To examine competitive developments such as mergers & acquisitions, agreements, collaborations, and partnerships, etc., in the global Anti-Obesity Drugs market.

- To identify and analyze the profile of leading players operating in the global Anti-Obesity Drugs market.

Questions And Answers: Global Anti-Obesity Drugs Market

Q1. What is the CAGR that the Anti-Obesity Drugs Market is expected to register through the projected duration?

Answer: The Anti-Obesity Drugs Market is likely to register a CAGR of 23% over the forecast period.

Q2. Which Are the Key Players in Global Anti-Obesity Drugs Market?

Answer: Novo Nordisk A/S, GlaxoSmithKline plc, VIVUS LLC, Currax Pharmaceuticals LLC, F. Hoffamann-La Roche Ltd., Pfizer Inc.

To Purchase This Report: https://www.marketstudyreport.com/securecheckout/paymenta/5659616?msfpaycode=sumsf

Contact Us:

Ritesh Tiwari
Head - Press and Media
Email: sales@marketstudyreport.com
Phone: 1-866-764-2150
MarketStudyReport.com

About Us:

Market Study Report is a hub for market intelligence products and services. We streamline the purchase of your market research reports and services through a single integrated platform by bringing all the major publishers and their services at one place. Our customers partner with Market Study Report, to ease their search and evaluation of market intelligence products and services and in turn focus on their company's core activities. If you are looking for research reports on global or regional markets, competitive information, emerging markets, and trends or just looking to stay on top of the curve then Market Study Report, is the platform that can help you in achieving any of these objectives.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Anti-Obesity Drugs Market Size to rise at 23% CAGR through 2028 | Novo Nordisk A/S, GlaxoSmithKline plc, VIVUS LLC, Currax Pharmaceuticals LLC, F. Hoffamann-La Roche Ltd., Pfizer Inc. here

News-ID: 2896588 • Views:

More Releases from Market Study Report

Wheelchair Tires Market Size to rise at 4.85% CAGR through 2028
Wheelchair Tires Market Size to rise at 4.85% CAGR through 2028
Market Study Report recently added a new title on 2023-2028 Global Wheelchair Tires Market Report from its database. The report provides study with in-depth overview, describing about the Product, Size, Share, Industry Scope and elaborates market outlook and status to 2028. Request Sample copy of this Report @ https://www.marketstudyreport.com/request-a-sample/5669807/ Global Wheelchair Tires Market Size was estimated at USD 402.34 million in 2022 and is projected to reach USD 560.42 million by 2028,
Global Vital Signs Monitors Market Size to witness a CAGR of 0.1% during 2023-2028
Global Vital Signs Monitors Market Size to witness a CAGR of 0.1% during 2023-20 …
Market Study Report recently added a new title on 2023-2028 Global Vital Signs Monitors Market Report from its database. The report provides study with in-depth overview, describing about the Product, Size, Share, Industry Scope and elaborates market outlook and status to 2028. Request Sample copy of this Report @ https://www.marketstudyreport.com/request-a-sample/5669877/ Global Vital Signs Monitors Market Size was estimated at USD 4811.69 million in 2022 and is projected to reach USD 4845.81 million
Outboard Electric Motors Market Size to Record 6.26% CAGR Through 2028
Outboard Electric Motors Market Size to Record 6.26% CAGR Through 2028
Market Study Report: The Report 2023-2028 Global Outboard Electric Motors Market Report explores the essential factors of the Outboard Electric Motors market considering such as industry situations, market demands, market players adopted business strategies and their growth scenario. The Global Outboard Electric Motors market has been separated by this report based on the key players profiles, Type, Application and Regions. Request Sample copy of this Report @ https://www.marketstudyreport.com/request-a-sample/5658245/
Robot Grippers Market Size growing at 13.33% CAGR to hit USD 5301.68 million by 2028
Robot Grippers Market Size growing at 13.33% CAGR to hit USD 5301.68 million by …
Global Robot Grippers Market Report added at Market Study Report offers industry size, share, growth, trends and forecast analysis up to 2028. Robot Grippers Market Report also covers top key players, porters five forces analysis and market segmentation in detail. This report examines the global Robot Grippers market and provides information regarding the revenue for the period 2023 to 2028. Request Sample copy of this Report @ https://www.marketstudyreport.com/request-a-sample/5658423/

All 5 Releases


More Releases for Drugs

Generic Drugs Market Application Anti-Infective Drugs, Anti-Arthritis Drugs, Ant …
Generic drugs are the medications that are developed to be similar to a medicine that is already commercially available in the market with a brand name. The generic drug is similar to the medicine available in terms of dosage, safety and strength, mode of administration, quality and intended use. Due to the similarities, generic drugs are capable of treating various diseases. Generic drugs are most cost effective than the branded
Cytotoxic Drugs Market Growing Demand for Antimetabolite Drugs
According to Precision Business Insights (PBI), the latest report, the cytotoxic drugs market is expected to be valued at USD 15,927.2 million in 2022 and is poised to grow at a significant CAGR of 2.2% over 2022-2028. The primary drivers of the expansion of the global cytotoxic drugs market include the increasing prevalence of cancer diseases, the increasing use and approval of cytotoxic drugs, and the increasing consumption of alcohol
Global Antithrombotic Drugs Market | Global Antithrombotic Drugs Industry | Glob …
Antithrombotic drugs are special drugs that help to prevent the formation of thrombus or clot. These drugs are used to reduce the formation of blood clots by reducing the capability of body to form a blood clot. Antithrombotic drugs act by preventing the production of vitamin K in the liver. Anticoagulant, antiplatelet, and thrombolytic agents are different types of antithrombotic agents that act by different clotting processes. Arterial & venous
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication
Hepatitis Drugs Market by Therapeutics, Diagnostics, Patient, Drugs Policy
The global hepatitis drugs market is growing due to increasing incidences of hepatitis and increasing support from government organizations. In addition, the growing geriatric population, and increasing R&D investments on hepatitis research and drug discovery are also driving the growth of the global hepatitis drugs market. Access Detailed Report Summary: https://www.psmarketresearch.com/market-analysis/hepatitis-drugs-market Among the various types, the hepatitis C segment is expected to be the largest segment, and expected to witness the fastest
Epilepsy Drugs Market by Country, Drugs, Company & Forecast
For More Information: https://renub-research.blogspot.com/2019/04/the-factors-that-are-driving-global.html Epilepsy is a chronic disease in which patient’s brain activities become abnormal due to seizures. Seizure is an unexpected rush of electrical activity in the brain. Seizure is categorized by two types - generalized seizures and focal or partial seizures. Generalized seizures affect the whole brain whereas focal or partial seizures affect just one part of the brain. Global epilepsy drugs market is expected to cross US$